Dr. Makeda Dawkins shares her journey through residency as a Black woman, offering insights on mentorship, cultural advocacy, ...

Funding will enable lead candidates CTX114 and CTX203 for AMD to enter clinical trials in the next year JERSEY CITY, N.J.--(BUSINESS WIRE)--Character Biosciences, a precision medicine company ...

The AMA’s new $12 million precision education grant program represents the next step in our ongoing work to reimagine medical education and lifelong learning.

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...

Precision BioSciences (NASDAQ:DTIL) is scheduled to announce Q4 earnings results on Wednesday, March 26th, before market open. The consensus EPS Estimate is -$2.94 (+27.6% Y/Y) and the consensus ...

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...

Explore Precision BioSciences stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for DTIL. Precision BioSciences Touts Encouraging Initial Safety And Antiviral ...

In the era of precision medicine, life sciences teams can utilise real-world data (RWD) to generate actionable real-world evidence (RWE) about how to develop and deliver more targeted medications ...

Belfast firm says arrangement with Partner Therapeutics for BIZENGRI brand should generate more than £4.5m in recurring ...

Reports Q4 revenue $600K, as compared to $7M for the quarter ended December 31, 2023. The decrease of $6.4 million in revenue during the ...

A new era of healthcare innovation has been ushered in by the evolution of the surgical robotics business in recent years.